Two Sigma Investments
UTMD icon

Two Sigma Investments’s Utah Medical Products UTMD Stock Holding History

Two Sigma Investments’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,153
Closed -$288K – 4942
2025
Q4 		$288K Sell
5,153
-344
-6% -$19.9K ﹤0.01% 3590
2025
Q3 		$346K Sell
5,497
-8,211
-60% -$486K ﹤0.01% 3153
2025
Q2 		$780K Sell
13,708
-13,588
-50% -$739K ﹤0.01% 2373
2025
Q1 		$1.53M Buy
27,296
+8,106
+42% +$486K ﹤0.01% 1912
2024
Q4 		$1.18M Buy
19,190
+783
+4% +$50.6K ﹤0.01% 2073
2024
Q3 		$1.23M Sell
18,407
-697
-4% -$47.3K ﹤0.01% 1999
2024
Q2 		$1.28M Sell
19,104
-7,346
-28% -$500K ﹤0.01% 1854
2024
Q1 		$1.88M Buy
26,450
+18,943
+252% +$1.42M ﹤0.01% 1528
2023
Q4 		$632K Sell
7,507
-3,200
-30% -$265K ﹤0.01% 2340
2023
Q3 		$921K Buy
10,707
+5,600
+110% +$517K ﹤0.01% 1984
2023
Q2 		$476K Buy
5,107
+1,155
+29% +$109K ﹤0.01% 2354
2023
Q1 		$375K Buy
+3,952
New +$363K ﹤0.01% 2322
2022
Q2 		– Sell
-5,996
Closed -$539K – 2957
2022
Q1 		$539K Buy
5,996
+3,097
+107% +$285K ﹤0.01% 1983
2021
Q4 		$290K Buy
+2,899
New +$296K ﹤0.01% 3668
2019
Q3 		– Sell
-3,611
Closed -$346K – 3823
2019
Q2 		$346K Buy
+3,611
New +$304K ﹤0.01% 2774
2019
Q1 		– Sell
-3,479
Closed -$289K – 3490
2018
Q4 		$289K Sell
3,479
-1,831
-34% -$161K ﹤0.01% 2477
2018
Q3 		$500K Buy
5,310
+2,809
+112% +$268K ﹤0.01% 2445
2018
Q2 		$275K Sell
2,501
-3,266
-57% -$341K ﹤0.01% 2994
2018
Q1 		$570K Sell
5,767
-3,019
-34% -$269K ﹤0.01% 2398
2017
Q4 		$715K Buy
8,786
+561
+7% +$43.8K ﹤0.01% 2189
2017
Q3 		$605K Buy
8,225
+1,840
+29% +$132K ﹤0.01% 2030
2017
Q2 		$462K Buy
6,385
+3,001
+89% +$198K ﹤0.01% 2393
2017
Q1 		$211K Sell
3,384
-100
-3% -$6.29K ﹤0.01% 2704
2016
Q4 		$253K Sell
3,484
-1,500
-30% -$97.5K ﹤0.01% 2831
2016
Q3 		$298K Sell
4,984
-2,001
-29% -$127K ﹤0.01% 2751
2016
Q2 		$440K Buy
+6,985
New +$450K ﹤0.01% 2323
2016
Q1 		– Sell
-3,498
Closed -$205K – 3152
2015
Q4 		$205K Buy
+3,498
New +$198K ﹤0.01% 2456
2015
Q3 		– Sell
-3,798
Closed -$226K – 2771
2015
Q2 		$226K Sell
3,798
-200
-5% -$11.3K ﹤0.01% 2571
2015
Q1 		$239K Hold
3,998
– – ﹤0.01% 2402
2014
Q4 		$240K Buy
+3,998
New +$221K ﹤0.01% 1997
2014
Q3 		– Sell
-3,998
Closed -$206K – 2067
2014
Q2 		$206K Hold
3,998
– – ﹤0.01% 1965
2014
Q1 		$231K Hold
3,998
– – ﹤0.01% 1773
2013
Q4 		$229K Hold
3,998
– – ﹤0.01% 1971
2013
Q3 		$238K Sell
3,998
-200
-5% -$10.9K ﹤0.01% 1576
2013
Q2 		$228K Buy
+4,198
New +$198K ﹤0.01% 1733

Other funds holding UTMD

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MA
Minerva Advisors Bala Cynwyd, Pennsylvania $155M AUM 35.49% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Investments's UTMD Position: Q1 2026 in Review

Two Sigma Investments sold out of Utah Medical Products (UTMD) in Q1 2026, closing a stake of 5,153 shares — an estimated $288K sold.

Two Sigma Investments first reported a position in UTMD in Q2 2013 and held it in 35 quarters. The position peaked at $1.88M in Q1 2024. 119 funds tracked by Wall St. Rank hold UTMD as of Q1 2026.

  • Two Sigma Investments reported no remaining Utah Medical Products position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Investments sold 5,153 Utah Medical Products shares in Q1 2026, an estimated $288K.
  • Two Sigma Investments first reported a position in Utah Medical Products in Q2 2013 and held it in 35 quarters.
  • Two Sigma Investments's Utah Medical Products position peaked at $1.88M in Q1 2024.
  • 119 funds tracked by Wall St. Rank held Utah Medical Products as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.